Back to Results
First PageMeta Content
Cancer treatments / Osteosarcoma / Anatomical pathology / Adjuvant therapy / Bone tumor / Chemotherapy / Medicine / Oncology / Sarcoma


Document Date: 2010-09-23 14:05:02

Open Document

File Size: 261,13 KB

Share Result on Facebook

City

Arlington / Denver / New York / Zurich / /

Company

Cook Inc. / COSS / Morinaga / European Osteosarcoma Intergroup / Scandinavian Sarcoma Group / Levin AG / Pathak AB / ABC / Surgical Oncology Inc. / Cox / Huvos AG / HP / /

Country

Korea / /

/

Event

FDA Phase / /

Facility

Children’s Hospital / The Institute / Luke’s Medical Center / Temple HT / /

/

IndustryTerm

magnetic resonance imaging / neoadjuvant chemotherapy protocol / venous access device / neoadjuvant protocol / postoperative protocol / recent magnetic resonance imaging / intravenous neoadjuvant protocol / disease site / osteosarcoma chemotherapy protocols / dose-intensified neoadjuvant protocol / preoperative protocol / /

MedicalCondition

prior cancers / histologic tumor / JE / pediatric nonmetastatic osteosarcomas / Primary Nonmetastatic Pediatric Osteosarcoma / high-grade osteogenic sarcoma / primary nonmetastatic osteosarcoma / localised osteosarcoma / uncontrolled prosthetic infections / small hypovascular tumor / metastatic disease / musculoskeletal tumors / good initial tumor / nonmetastatic osteosarcoma / progressive osteosarcoma / protracted neutropenia / residual tumor / tumor / large tumors / cancer / tumors / neoplasm / Untreated osteosarcoma / osteosarcoma study group’s / neutropenia / osteosarcoma / lung metastasis / good primary tumor / non-metastatic osteosarcoma / high grade osteosarcoma / operable osteosarcoma / myocutaneous inflammatory changes / painful inflammation / extremity tumors / metastases / primary osteosarcoma / primary tumor / nonmetastatic disease / osteosarcoma active chemotherapeutic agents / metastasis / extremity osteosarcomas / cell necrosis / Abdominal-wall myositis / diminished tumor / Primary osteogenic sarcoma / tumor size / pediatric osteosarcoma / primary nonmetastatic extremity osteosarcomas / Osteogenic sarcoma / febrile neutropenia / definitive tumor / inflammatory changes / viable tumor / femoral osteosarcoma / compare tumor / MS / malignant bone tumors / primary tumors / improved tumor / congestive heart failure / Initial tumor / necrosis / bacteremia / primary disease / dark viable tumor / disease / percentage necrosis / progressive disease / partial deafness / extremity sarcomas / pulmonary metastases / mucositis / pain / tumor necrosis / previously untreated / high-grade osteosarcoma / osteosarcoma chemotherapy protocols / nonmetastatic primary osteosarcoma / le Cancer / high-grade / nonmetastatic osteosarcoma / inflammation / ET AL. in tumor / /

MedicalTreatment

nutritional support / bed rest / surgical treatment / surgery / catheterization / chemo / adjuvant chemotherapy / antibiotics / alternative therapy / chemotherapy / catheter / amputation / amputations / /

Organization

Presbyterian/St. Luke’s Medical Center / Institute for Limb Preservation / Society of Surgical Oncology / National Cancer Institute / Children’s Hospital / Department of Defense / /

Person

Lorrie Odom / Brandt A. Jamroz / Anne B. Camozzi / Carter SR / Sanford D. Peck / Arch Pathol / Cynthia M. Kelly / NED CDF CDF DOD CDF / NED CDF CDF NED CDF / NED CDF CDF CDF CDF / Ann Surg Oncol / Ann Oncol / Sydney L. Stevens / John W. Cullen / Kyle Fink / Ann Plast Surg / Mike V / Patsy McGuire Cullen / /

Position

Representative / co-operative / /

Product

carboplatin / cisplatin / etoposide / ifosfamide / COSS-86 / OS-3b / OS-3 / /

ProvinceOrState

Alabama / Colorado / Iowa / /

PublishedMedium

Lippincott Williams & Wilkins / /

RadioStation

Surg Am 1970 / /

Technology

x-ray / istituto ortopedico rizzoli/osteosarcoma-2 protocol / DOX/intra-arterial CDDP protocol / neoadjuvant chemotherapy protocol / preoperative protocol / magnetic resonance imaging / chemotherapy / postoperative protocol / two osteosarcoma chemotherapy protocols / Rizzoli IOR/OS-3b protocol / intravenous neoadjuvant protocol / dose-intensified neoadjuvant protocol / following neoadjuvant chemotherapy / /

URL

www.annalssurgicaloncology.org / /

SocialTag